Hongquan Xing
1 Minde Road
Nanchang, 330006, China
Nanchang, 330006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Pulmonary artery diameter and sudden death in PAH: Is 40 mm a true threshold or a warning value?
Journal: European journal of internal medicine
Published: July 27, 2026
Baseline or dynamic prediction after venous thromboembolism? Clarifying the clinical use of the CAVE score for occult cancer.
Journal: European journal of internal medicine
Published: June 02, 2026
Ribonucleotide reductase regulatory subunit M2 as a macromolecular target bridging small cell lung cancer progression and SARS-CoV-2 infection.
Journal: International journal of biological macromolecules
Published: December 20, 2025
Exploratory multiomics analysis identifies WDR17 as a potential biomarker of tyrosine kinase inhibitor resistance in lung adenocarcinoma.
Journal: Discover oncology
Published: December 12, 2025
Targeting high endothelial venules: potential strategies for cancer treatment.
Journal: Annals of medicine
Published: December 03, 2025
Primary tumor resection: a new hope or an old illusion for patients with metastatic non-small cell lung neuroendocrine tumors?
Journal: World journal of surgical oncology
Published: April 13, 2025
Tracheal, bronchus, and lung cancer among older adults: thirty-year global burden trends, precision medicine breakthroughs, and lingering barriers.
Journal: BMC cancer
Published: March 17, 2025
Bibliometric analysis of current trends and emerging patterns in the application of nanomaterials for non-small cell lung cancer.
Journal: Discover oncology
Published: January 12, 2025
The association between triglyceride glucose-body mass index and overall survival in postoperative patient with lung cancer.
Journal: Frontiers in endocrinology
Published: November 15, 2024
Early death incidence and prediction in stage IV large cell neuroendocrine carcinoma of the lung.
Journal: Medicine
Published: September 17, 2024
Crizotinib resistance reversal in ALK-positive lung cancer through zeolitic imidazolate framework-based mitochondrial damage.
Journal: Acta biomaterialia
Published: May 24, 2024
Last Updated: 09/26/2026